Ascorbic acid Completed Phase 2 Trials for Hemodialysis Access Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03524846Ascorbic Acid on Restenosis of Dysfunctional Hemodialysis Vascular Access